<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">mimmun</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинская иммунология</journal-title><trans-title-group xml:lang="en"><trans-title>Medical Immunology (Russia)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1563-0625</issn><issn pub-type="epub">2313-741X</issn><publisher><publisher-name>SPb RAACI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15789/1563-0625-EDO-2315</article-id><article-id custom-type="elpub" pub-id-type="custom">mimmun-2439</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>МАТЕРИАЛЫ ФОРУМА "ДНИ ИММУНОЛОГИИ В СПБ" 2021</subject></subj-group></article-categories><title-group><article-title>РАННЯЯ ДИАГНОСТИКА АУТОВОСПАЛИТЕЛЬНЫХ НАРУШЕНИЙ, АССОЦИИРОВАННЫХ С ПОСТВИРУСНЫМ СИНДРОМОМ ХРОНИЧЕСКОЙ УСТАЛОСТИ И КОГНИТИВНЫМИ РАССТРОЙСТВАМИ ПРИ ХРОНИЧЕСКИХ МИКСТ ГЕРПЕС-ВИРУСНЫХ ИНФЕКЦИЯХ</article-title><trans-title-group xml:lang="en"><trans-title>EARLY DIAGNOSTICS OF AUTOINFLAMMATORY DISORDERS ASSOCIATED WITH POST-VIRAL CHRONIC FATIGUE SYNDROME AND COGNITIVE IMPAIRMENTS IN CHRONIC MIXED HERPES VIRAL INFECTIONS</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Нестерова</surname><given-names>И. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Nesterova</surname><given-names>I. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.м.н., профессор кафедры аллергологии и иммунологии, факультет непрерывного медицинского образования,</p><p>Москва</p></bio><bio xml:lang="en"><p>PhD, MD (Medicine), Professor, Department of Allergology and Immunology, Faculty of Continuing MedicalEducation,</p><p>Moscow</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Халтурина</surname><given-names>Е. О.</given-names></name><name name-style="western" xml:lang="en"><surname>Khalturina</surname><given-names>E. O.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.м.н., доцент кафедры микробиологии, вирусологии и иммунологии,</p><p>117452, Москва, ул. Моховая, 11, корп 10</p></bio><bio xml:lang="en"><p>PhD (Medicine), Associate Professor, Department of Microbiology, Virology and Immunology, </p><p>117452, Moscow, Mochovaya, 11, bild.10</p></bio><email xlink:type="simple">jane_k@inbox.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГАОУ ВО «Российский университет дружбы народов»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Peoples’ Friendship University of Russia</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГАОУ ВО «Первый московский медицинский университет имени И.М. Сеченова» Министерства здравоохранения РФ (Сеченовский университет)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>I. Sechenov First Moscow State Medical University (Sechenov University)</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2021</year></pub-date><pub-date pub-type="epub"><day>19</day><month>10</month><year>2021</year></pub-date><volume>23</volume><issue>4</issue><fpage>975</fpage><lpage>980</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Нестерова И.В., Халтурина Е.О., 2021</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="ru">Нестерова И.В., Халтурина Е.О.</copyright-holder><copyright-holder xml:lang="en">Nesterova I.V., Khalturina E.O.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.mimmun.ru/mimmun/article/view/2439">https://www.mimmun.ru/mimmun/article/view/2439</self-uri><abstract><p>Неуклонный рост числа аутоиммунных заболеваний и иммуноопосредованных аутовоспалительных процессов вызывает повышенный интерес врачей всех специальностей к этой теме и делает крайне актуальным вопрос раннего выявления аутоиммунных расстройств/аутоиммунного синдрома (AС). Зачастую эти нарушения развиваются на фоне атипичного течения хронических активных вирусных инфекций, вызываемых персистирующими вирусами, в частности вирусами семейства Herpesviridae (АХА ГВИ) и остаются не диагностированными вследствие полисимптомности опосредуемых ими нарушений и различными «клиническим масками» вызываемых расстройств.</p><p>Разработанный нами полуколичественный метод скрининговой оценки содержания аутоантител в сыворотке крови пациентов, страдающих АХА ГВИ, вызываемой герпес-вирусами, с использованием метода ИФА (Immunodot), является высокоспецифичным, скрининговым методом, который может позволить проводить объективную оценку динамики течения аутоиммунного процесса, а также осуществлять контроль за эффективностью проводимой комплексной противовирусной и иммуномодулирующей терапии.</p><p>Детекция аутоантител различной специфичности в сыворотке крови пациентов, страдающих атипичной хронической активной инфекцией, вызываемой герпес-вирусами (АХАИ), является ранним диагностическим маркером, необходимым, в первую очередь, для выявления аутоиммунной патологии нервной системы, которая ассоциирована с длительным течением активного микст-герпесвирусного процесса. </p></abstract><trans-abstract xml:lang="en"><p>The steady increase in the number of autoimmune diseases and immune-mediated autoinflammatory processes causes an increased interest of doctors of all specialties in this topic and makes the issue of early detection of autoimmune disorders / autoimmune syndrome (AS) extremely urgent. These disorders often develop against the backdrop of an atypical stream of chronic active viral infections caused by persistent viruses, in particular those of the Herpesviridae family, and remain undiagnosed due to polysymptomatic disease, and various “clinical masks” of the disorders caused by them. The semi-quantitative method developed by us for screening assessment of the content of autoantibodies in the blood serum of patients suffering from ACAI caused by herpes viruses using the ELISA method (Immunodot) is a highly specific screening method that can allow for an objective assessment of the dynamics of the autoimmune process, as well as control the effectiveness of the ongoing complex antiviral and immunomodulatory therapy. The detection of autoantibodies of various specificity in the blood serum of patients suffering from an atypical chronic active infection caused by herpes viruses (ACAI) is an early diagnostic marker, necessary, first of all, to identify autoimmune pathology of the nervous system, which is associated with a long course of the active mixed herpes-viral process. </p></trans-abstract><kwd-group xml:lang="ru"><kwd>герпесвирусы</kwd><kwd>аутоантитела</kwd><kwd>ганглиозиды</kwd><kwd>аутоиммунитет</kwd><kwd>иммунная дисфункция</kwd><kwd>пост-вирусный синдром хронической усталости</kwd></kwd-group><kwd-group xml:lang="en"><kwd>herpesviruses</kwd><kwd>autoantibodies</kwd><kwd>gangliosides</kwd><kwd>autoimmunity</kwd><kwd>immune dysfunction</kwd><kwd>post-viral chronic fatigue syndrome</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Bravender T. Epstein-Barr virus, cytomegalovirus, and infectious mononucleosis. Adolesc. Med. State Art Rev., 2010, Vol. 21, no. 2, pp. 251-264.</mixed-citation><mixed-citation xml:lang="en">Bravender T. Epstein-Barr virus, cytomegalovirus, and infectious mononucleosis. Adolesc. Med. State Art Rev., 2010, Vol. 21, no. 2, pp. 251-264.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Ercolini A.M., Miller S.D. The role of infections in autoimmune disease. Clin. Exp. Immunol., 2009, Vol. 155, no. 1, pp. 1-15.</mixed-citation><mixed-citation xml:lang="en">Ercolini A.M., Miller S.D. The role of infections in autoimmune disease. Clin. Exp. Immunol., 2009, Vol. 155, no. 1, pp. 1-15.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Fujinami R.S., von Herrath M.G., Christen U., Whitton J.L., von Herrath M.G. Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease mechanisms of immunopathology that could lead to autoimmune disease. Society, 2006, Vol. 19, no. 1, pp. 80-94.</mixed-citation><mixed-citation xml:lang="en">Fujinami R.S., von Herrath M.G., Christen U., Whitton J.L., von Herrath M.G. Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease mechanisms of immunopathology that could lead to autoimmune disease. Society, 2006, Vol. 19, no. 1, pp. 80-94.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Hussein H.M., Rahal E.A. The role of viral infections in the development of autoimmune diseases. Crit. Rev. Microbiol., 2019, Vol. 45, no. 4. pp. 394-412.</mixed-citation><mixed-citation xml:lang="en">Hussein H.M., Rahal E.A. The role of viral infections in the development of autoimmune diseases. Crit. Rev. Microbiol., 2019, Vol. 45, no. 4. pp. 394-412.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Kanduc D. The comparative biochemistry of viruses and humans: An evolutionary path towards autoimmunity. Biol. Chem., 2019, Vol. 400, no. 5, pp. 629-638.</mixed-citation><mixed-citation xml:lang="en">Kanduc D. The comparative biochemistry of viruses and humans: An evolutionary path towards autoimmunity. Biol. Chem., 2019, Vol. 400, no. 5, pp. 629-638.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Kutok J., Wang F. Spectrum of Epstein–Barr virus-associated diseases. Annu. Rev. Pathol., 2006, Vol. 1, pp. 375-404.</mixed-citation><mixed-citation xml:lang="en">Kutok J., Wang F. Spectrum of Epstein–Barr virus-associated diseases. Annu. Rev. Pathol., 2006, Vol. 1, pp. 375-404.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Levin L., Munger K., O’Reilly E., Falk K., Ascherio A. Primary infection with Epstein–Barr virus and risk of multiple sclerosis. Ann. Neurol., 2010, Vol. 67, pp. 824-830.</mixed-citation><mixed-citation xml:lang="en">Levin L., Munger K., O’Reilly E., Falk K., Ascherio A. Primary infection with Epstein–Barr virus and risk of multiple sclerosis. Ann. Neurol., 2010, Vol. 67, pp. 824-830.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Rojas M., Restrepo-Jimenes P. Molecular mimicry and autoimmunity. J. Autoimmun., 2018, Vol. 95, pp. 100-123.</mixed-citation><mixed-citation xml:lang="en">Rojas M., Restrepo-Jimenes P. Molecular mimicry and autoimmunity. J. Autoimmun., 2018, Vol. 95, pp. 100-123.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Serafini B., Rosicarelli B., Franciotto D. Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain. J. Exp. Med., 2007, Vol. 204, no. 12, pp. 2899-2912.</mixed-citation><mixed-citation xml:lang="en">Serafini B., Rosicarelli B., Franciotto D. Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain. J. Exp. Med., 2007, Vol. 204, no. 12, pp. 2899-2912.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Tracy S.I., Kalacheva K., Lunemann J.D., Luzuiaga K., Middeldorp J., Thorley-Lawson D.A. Persistence of Epstein–Barr virus in self-reactive memory B cells. J. Viorol., 2012, Vol. 88, no. 22, pp. 12330-12340.</mixed-citation><mixed-citation xml:lang="en">Tracy S.I., Kalacheva K., Lunemann J.D., Luzuiaga K., Middeldorp J., Thorley-Lawson D.A. Persistence of Epstein–Barr virus in self-reactive memory B cells. J. Viorol., 2012, Vol. 88, no. 22, pp. 12330-12340.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Tuohy V.K., Kinkel R.P. Epitope spreading: A mechanism for progression of autoimmune disease. Arch. Immunol. Ther. Exp. (Warsz), 2000, Vol. 48, no. 5, pp. 347-351.</mixed-citation><mixed-citation xml:lang="en">Tuohy V.K., Kinkel R.P. Epitope spreading: A mechanism for progression of autoimmune disease. Arch. Immunol. Ther. Exp. (Warsz), 2000, Vol. 48, no. 5, pp. 347-351.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
